对2023年期间批准的新药的合成方法
Scott P France1, Erick A Lindsey2, Emma L McInturff3
1Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
Journal of medicinal chemistry
|February 3, 2025
概括
本综述详细介绍了2023年批准的28种小分子药物的合成途径. 它涵盖了它们的机制,发现和发展,强调了合成化学.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药物发现 药物发现 药物发现
背景情况:
- 年度审查系列专注于新药批准.
- 合成化学对于药物开发和患者治疗至关重要.
- 2023年将在全球范围内批准28种新的小分子药物.
研究的目的:
- 审查2023年批准的28种小分子药物的合成途径.
- 为这些新药的发现,开发和合成策略提供见解.
- 突出合成化学在提供新疗法的作用.
主要方法:
- 主要和专利来源的文献审查.
- 对2023年批准的药物合成方法的分析.
- 药物的作用机制和发展史的总结.
主要成果:
- 介绍了2023年批准的28种小分子药物的详细合成途径.
- 包含了关于每个药物的作用机制和发现历史的信息.
- 确定了用于临床研究和开发的可能合成途径.
结论:
- 合成化学在新药的成功开发和交付中发挥着关键作用.
- 该综述提供了一个全面的综合策略的综合概述,用于最近的制药进步.
- 了解这些合成路径有助于未来的药物开发和制造过程.
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Synthetic Biology
4.7K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
4.7K
Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Nomenclature
1.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.6K


